Clinical trial
The Effect of Ribose on B-Type Natriuretic Peptide (BNP) Levels in Congestive…
NCT00329485 · Valen Labs, Industry · Terminated
Key facts
| NCT number | NCT00329485 |
|---|---|
| Title | The Effect of Ribose on B-Type Natriuretic Peptide (BNP) Levels in Congestive Heart Failure Patients |
| Official title | The Effect of Ribose on B-Type Natriuretic Peptide Levels in Congestive Heart Failure Patients |
| Lead sponsor | Valen Labs, Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Congestive Heart Failure |
| Intervention type | Drug |
| Interventions | CORvalen (D-Ribose) |
| Enrollment | 120 |
| Start date | Jun 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | May 24, 2006 |
| Last update posted | Aug 2, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: